Herbert Tilg is an Austrian internist and professor at the Medical University of Innsbruck. He is known for his work on chronic inflammatory mechanisms and the role of inflammatory mediators (cytokines). Tilg working in the fields of chronic inflammation and the role of inflammatory mediators such as cytokines in various diseases in the Department of Gastroenterology and Hepatology. The focus researches are in the area of fatty liver disease and inflammatory bowel disease. Tilg is considered one of the pioneers in the study of inflammation, immune mediators and liver disease. Recently, his interest focused on the role of microbiota in metabolic inflammation and associated diseases such as fatty liver disease and type 2 diabetes. He could also set up internationally recognized disease hypotheses. Tilg is since 2009 co-editor of the renowned journal "GOOD" and a member of numerous editorial boards of international journals.